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1. Introduction
Diabetes mellitus (DM), often simply referred to as diabetes, is a group of metabolic diseases
in which a patient has high blood sugar, either because the body does not produce enough
insulin, or because cells do not respond to the insulin that is produced. This high blood sug‐
ar produces the classical symptoms of polyuria (frequent urination), polydipsia (increased
thirst) and polyphagia (increased hunger). It is characterized by hyperglycaemia due to de‐
fective insulin action, insulin secretion or both. Several medicinal plants are used in the
management of diabetes mellitus (Akah et al., 2002). According to the World Health Organi‐
zation (WHO), there are approximately 160,000 diabetics worldwide, the number of diabet‐
ics has double in the last few years and is expected to double once again in the year 2025
(Beretta, 2001). Due to its high prevalence and potential deleterious effect on a patient physi‐
cal and psychological state, diabetes is a major medical concern (Macedo et al., 2002). The
disease remains incurable and can only be controlled with drugs. The three main types of
diabetes mellitus (DM) are: Type 1 DM results from the body's failure to produce insulin,
and presently requires the administration of insulin for treatment (Lambert et al., 2002). It is
also referred to as insulin-dependent diabetes mellitus (IDDM) or "juvenile" diabetes). Type
2 DM results from insulin resistance, a condition in which cells fail to use insulin properly,
sometimes combined with an absolute insulin deficiency (Boussageon et al., 2011). It is for‐
merly referred to as noninsulin-dependent diabetes mellitus (NIDDM) or "adult-onset" dia‐
betes). Gestational diabetes occurs when pregnant patient, who have never had diabetes
before, have a high blood glucose level during pregnancy. It may precede development of
type 2 DM (Sattar et al., 2010).
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Several plants have been used in folkloric medicine for the treatment and prevention of in‐
fectious and non-infectious diseases in man and his animals and this has led to renewed sci‐
entific interest in the use of plants for these purposes (Oridupa et al. 2011). There is global
resurgence in the use of herbal preparations and in some developing countries like Nigeria;
it is being gradually integrated into the primary and secondary health care systems. Nearly
all societies have used herbal materials as sources of medicines and the development of
these herbal medicines depended on local botanical flora (Adedapo et al., 2009).
Phyllanthus amarus belongs to the family Euphorbiaceae (the spurge family) of which the
largest genus is the genus Euphorbia. The plant is known to originate from Malaysia. The
species Phyllanthus amarus is a small tropical herb, which occurs widely as a rainy-season
weed throughout the hotter parts of India (Bagchi et al., 1992). The widespread usage of this
herb has prompted several investigations (Calixto et al., 1998; Odetola and Akojenu, 2000;
Adeneye et al., 2006). The plant has a history of use in Ayurverdic medicine for over 2000
years as well as a wide variety of traditional applications. The plant is commonly found in
Southern Nigeria, Sierra Leone and Equatorial Guinea. It also occurs in Ghana and other
parts of tropical Africa (Irvine, 1930; Adedapo et al., 2005). It is a weed of cultivated land
and in waste spaces, it is common to find it growing and spreading freely along the road
sides, under flower beds and in many other places (Burkill, 1994). For this reason, grazing
animals are prone to consuming this plant along with their feed particularly in drier tropical
climates where lush green grass is not often available (Adedapo, 2002).
Many studies have thus been carried out on the plant in various parts of the world but there
is a resurgence of interest in this plant as antidiabetic agent. The present study was therefore
undertaken to investigate the phytochemical constituents, anti-diabetic and safety potentials
of the aqueous leaf extract of Phyllanthus amarus Schum in experimental animals especially
that diabetes has assumed a global dimension as a non-communicable disease.
2. Material and methods
2.1. Plant material and preparation of extracts
Fresh leaves of Phyllanthus amarus Schum were collected from the campus of the University
of Ibadan, Nigeria in March 2012. The leaves were identified by botanists and a voucher
specimen (UIH ADE/003/2012) deposited at the herbarium of the Department of Botany,
University of Ibadan. The ground plant material (200 g) was shaken in 1 L distilled water for
48 h on an orbital shaker at room temperature of 24°C. The extract was filtered using a Buck‐
ner funnel and Whatman No 1 filter paper. The filtrate was concentrated to dryness under
reduced pressure at 40ºC using a rotary evaporator. The thick solution was lyophilized us‐
ing freeze drying system for biological investigations. The extract yield was 13.85%.
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2.2. Animals
The animals used in this study were male Wistar rats weighing between 100 and 200g as
well as mice weighing between 15 and 30g. They were maintained at the Experimental Ani‐
mal House of the Faculty of Veterinary Medicine, University of Ibadan in rat cages and fed
on commercial rabbit cubes (Ladokun and Son Livestock Feeds, Nigeria Ltd). The animals
were allowed free access to clean fresh water in bottles ad libitum. All experimental protocols
were in compliance with University of Ibadan Ethics Committee on Research in Animals as
well as internationally accepted principles for laboratory animal use and care.
2.3. Chemicals
Alloxan used in this study was obtained from Sigma-Aldrich (Chemie Gmbh, Steinheim,
Denmark). The standard drug used in the various experiments was glibenclamide. The
chemical and drug used were of analytical grade. Normal saline and distilled water were al‐
so used in this study.
2.4. Phytochemical screening
The phytochemical analysis was performed on the ground (powered) leaf of P. amarus for
identification of the constituents. The constituents tested for were alkaloids, tannins, sapo‐
nins, anthraquinones, cardiac glycosides and flavonoids as described by Trease and Evans
(1983); Abate (1989); Shale et al., (1999); Evans, (2002); Moody et al., (2006) and Sawadogo et
al., (2006).
2.5. Acute toxicity test
The acute toxicity of P. amarus aqueous was determined in mice according to the method of
Hilaly et al. (2004) with slight modifications. Mice fasted for 16 h were randomly divided in‐
to groups of six mice per group. Graded doses of the plant’s extract (100, 200, 400, 800 and
1600 mg/kg p.o.) were separately administered to the mice in each of the groups by means of
bulbed steel needle. All the mice in the groups were then allowed free access to food and
water and observed over a period of 48 h for signs of acute toxicity. The number of deaths
within this period of time was recorded.
3. Antidiabetic studies
3.1. Hypoglycaemic activity test
The hypoglycaemic effect of the aqueous extract was studied in alloxan-induced diabetic
rats. The rats were fasted for 8 hours but allowed free access to water. At the end of the fast‐
ing period, the basal fasting blood glucose (FBG) level of the rats was determined. Subse‐
quently, diabetes was induced by single intraperitoneal injection of alloxan monohydrate
(70 mg/kg) (Aruna et al., 1999) and normal feeding maintained thereafter. Five days later,
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blood was drawn from each rat and the blood glucose level was measured to establish dia‐
betes. Animals with blood glucose level ≥225mg/dl was considered to be diabetic and used
for this study. The diabetic animals were randomly divided into four groups (n=5) and re‐
ceived oral administration of aqueous extract (200 and 400 mg/kg), Distilled water (5ml/kg)
and Glibenclamide (0.2 mg/kg) respectively. Aqueous extract was dissolved in distil water.
Blood glucose was then measured before (i.e. 0 h) and at 0.5, 1, 2 and 4 h after treatment.
3.2. Normoglycaemic activity
Animals fasted overnight were randomly divided into four groups (n=5) and received oral
administration of the extract (200 and 400mg/kg), glibenclamide (0.2mg/kg) and vehicle con‐
trol (5ml/kg) respectively. The blood glucose level of each animal was measured prior to
(pretreatment) and at 0.5, 1, 2 and 4hour after extract administration (Okoli et al., 2010).
3.3. Oral glucose tolerance test
Animals were fasted for 16h but with free access to water were randomly divided into four
groups (n=5) and received oral administration of the aqueous extract (200 and 400mg/kg),
glibenclamide (0.2mg/kg) and vehicle control (5ml/kg) respectively. Ninety minutes later,
the rats were fed with glucose (4g/kg). The blood glucose level of animals in each group was
then measured before (0) and at 30, 60, 90, 120, 150, 180 min after glucose load (Okoli et al.,
2010).
3.4. Antidiabetic activity test
The antidiabetic effect of the plant extract was studied by evaluating the effect of its chronic
administration on the blood glucose level of alloxan-induced diabetic rats. The basal fasting
blood glucose (FBG) of the rats was determined and diabetes was induced as described be‐
fore. 25 diabetic rats with glucose level ≥225 were selected and used for the study. The rats
were fasted for 8h but allowed free access to water (Okoli et al., 2010). They were then divid‐
ed randomly into five groups (n=5) and received oral administration of extract (200 and
400mg/kg), glibenclamide (0.2mg/kg, diabetic control), extract (200mg/kg) and the vehicle
(5ml/kg) both of which serve as non diabetic control. The treatment was administered orally
to the animals once daily for 28 days. Blood glucose level was then measured as described
before (pretreatment) and on days 14 and 28 after commencement of the treatment. The
body weight of each animal was also measured on these days.
3.5. Effects of the extract on lipid profile of diabetic rats
The effect of the extract on the lipid profile of treated diabetic rats was studied by monitor‐
ing the cholesterol and triglyceride levels. Blood samples were collected by ocular puncture,
transferred into test tubes and centrifuged at 3000 rpm for 5 mins. The serum was collected
and the total cholesterol and triglyceride levels of each sample were separately determined
by enzymatic colorimetric method (Muller et al., 1977) using reagent kits. Lipid levels of dia‐
betic animals were measured before (Basal) and after the induction of diabetes (pre-treat‐
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ment) as well as on days 14 and 28 after commencement of treatment. The absorbance of
each sample containing the reaction mixture with or without serum was read at 540nm in a
UV spectrophotometer. Total cholesterol or triglyceride is calculated using the formula: To‐
tal cholesterol (mg/dl) = SAod/STod x 200, where SAod = optical density of test sample and
STod = optical density of standard.
3.6. Effects of the extract on haemoglobin and cell counts of diabetic rats
The effect of chronic administration of the extract on haemoglobin (Hb) and cell counts
[white blood cells (WBC) and red blood cells (RBC)] of diabetic rats was also determined.
Blood samples were collected by ocular puncture using haematocrit tubes, transferred into
EDTA-containing test tubes and placed in a haematology analyzer (Abacus Junior®, Buda‐
pest-Hungary) for determination of the parameters. Measurements were taken before (bas‐
al) and after the induction of diabetes (Pre-treatment) as well as on days 14 and 28 after the
commencement of treatment (Post-treatment).
3.7. Estimation of haemoglobin
Cyanohaemoglobin method was used for this purpose (Coles, 1986). Four mls of Drabkin´s
solution (diluents) was placed in a tube, 0.02ml of the collected blood sample was put in the
tube using pipette and the pipette was rinsed for more than three times. The mixture was
stirred well and allowed to stand for 10minutes. This was read in a colorimeter at 540nm
wavelength. The equivalent haemoglobin was read from a calibration curve or table. The
haemoglobin value of the blood sample was calculated as:
Photometer reading of unknown x g% Hb value of standard x DF/Photometer reading of
standard
DF = dilution factor and it was calculated as:
Volume of the whole blood used + volume of diluent/volume of whole blood used.
It is expressed in gram percent.
3.8. Determination of erythrocyte (rbc) count
Erythrocyte diluting pipette marked 101 above the bulb was used to draw the blood sample
up to exactly 0.5mark. The tip of the pipette was then inserted into the erythrocyte diluting
fluid - Gower´s solution and through a steady suction; the pipette was filled with the fluid
to the 101 line above the bulb, rotating it gently while filling. The pipette was brought to a
horizontal position and finger tip was placed over the tip before removing the rubber tub‐
ing. The pipette was shaken for more than 30minutes in a mechanical shaker; the haemocy‐
tometer was then filled with the diluted blood and then allowed to stand for a few minutes
for the cells to settle. The erythrocytes were then counted under microscope lens (x 40 objec‐
tive) counting all the erythrocytes in the 5 of the 25 small squares in the central area. Each of
the 5 small squares to be counted was bordered by double or triple lines and was divided
into 16 smaller squares. A total of 80 of these small squares were counted. The cells were
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counted beginning at the left of the top row of small squares, then from right to left for the
next row and so on.
Calculation
Cells counted x 10(0.1mm depth) x 5(1/5 of sqmm) x 200(1:200) dilution = erythrocytes per
cu mm.
OR
The sum of the cells in the five small squares multiplied by 10,000 = total erythrocytes per cu
mm (Coles, 1986)
3.9. Determination of leucocyte (wbc) count
Leucocyte diluting pipetting was used to draw the blood sample to a point marked 0.5 and
filled with leucocyte diluting fluid up to the 11mark above the bulb. The mixture was shak‐
en for 3minutes until well mixed. Two to three drops from the pipette was discarded before
filling the counting chamber of haemocytometer. The leucocytes were allowed to settle for
1minute. The leucocytes in the larger squares of haemocytometer chamber were counted
and multiplied by 50 to obtain the total number of white blood cells (Coles, 1986).
Calculation:
Cells counted x 20 (1:20 dilution) x 10(0.1mm depth)/4 (no of sq mm counted)
= WBC/cubic mm
OR
The sum of the cell counted in the 4 corner squares multiplied by 50 = total leucocytes per
cubic mm.
4. Histological studies on the liver, kidney and pancreas
The effect of the extracts on tissue architecture of the pancreas of treated diabetic rats was
evaluated by histological studies of tissue sections obtained from the animals. On day 28 of
the experiment, one animal was randomly selected from the different groups and sacrificed
by over-dose of chloroform anaesthesia. The whole pancreas from each animal was removed
and placed in 10% formalin in normal saline for histological studies. The isolated organ was
placed in an automatic tissue processor for 24 hrs. After 24 hrs, the tissues were solidified in
molten wax and sectioned using automatic tissue sectioner. The tissue sections were then
fixed on slides with haematoxylin and eosin. The stained slides were fixed with mountant,
allowed to dry and viewed under the microscope (x400). This procedure was repeated for
the liver and kidney collected from the sacrificed animals.
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4.1. Statistical analysis
Data was analyzed using graph pad prism 5 and the results expressed as mean ± SD. The
results were further subjected to one way ANOVA for comparisons and differences between
means were considered significant at P< 0.05.
5. Results and discussion
Phytochemical screening of the leaves of P. amarus showed the presence of alkaloids, tannin,
flavonoids, saponin, anthraquinones and cardiac glycosides. Flavonoids and tannins are
phenolic compounds and plant phenolics are also a major group of compounds that act as
primary antioxidants or free radical scavengers (Adedapo et al., 2008a, 2008b, Ayoola et al.,
2008). Tannins and saponins are also found to be effective antioxidants, antimicrobial, and
anti-carcinogenic agents (Lai et al., 2010). Polyphenolic compounds are ubiquitous in foods
of plant origin, and thus they constitute an integral part of the human diet (Bravo 1998). In‐
terest in polyphenols has greatly increased recently because these phytochemicals are
known to suppress rates of degenerative processes such as cardiovascular disorders and
cancer (Bravo 1998, Duthie 2000, Huang et al., 2007; Jimoh et al., 2010). Some of these poten‐
tial health benefits of polyphenolic substances have been related to the action of these com‐
pounds as antioxidants, free radical scavengers, quenchers of singlet and triplet oxygen and
inhibitors of peroxidation (Li-Chen et al., 2005). As a group, phenolic compounds have been
found to be strong antioxidants against free radicals and other reactive oxygen species, the
major cause of many chronic human diseases (Kyung-Hee et al., 2005, Chen and Yen 2007).
In the acute toxicity test, no death was recorded in all the groups. All the mice appeared to
be normal and none of them showed any visible signs of toxicity. Acute oral administration
of Phyllanthus amarus to mice indicated that the plant is non toxic even at the dose of
1600mg/kg body weight. It thus showed that this plant is safe for medicinal use at this dose.
The aqueous extract caused a significant (P<0.05) dose related reduction in the fasting blood
glucose (FBG) of normoglycaemic rats. Maximum reduction occurred within 2hr post- treat‐
ment with 400mg/kg dose of the extract (Table 1). In this study, experimental evaluation of
the antidiabetic potentials of P. amarus has shown that single oral administration of the ex‐
tract to normal rats reduced fasting blood glucose which suggests an inherent hypoglycae‐
mic effect (Table 2). The extract also suppressed the postprandial rise in blood glucose in
normal rats following a heavy glucose meal with maximum suppressive effect coinciding
with the time of peak blood glucose level after the meal (Table 3). Chronic hyperglycaemia
in DM is a risk factor constantly fuelled by postprandial elevation of blood glucose. Control
of postprandial hyperglycaemia in diabetes is of great importance due to its close relation to
the risk of micro and macro-vascular complications and death (Balkau, 2000; Ceriello, 2005).
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Treatment Dose
mg/kg
Fasting Blood Glucose level (mg/dl)
Pretreatment 0.5hr 1hr 2hr 4hr
Control 2ml/kg 72.4±5.5 71.2±6.0 70.6±5.6 70±5.1 70±4.7
Glibenclamide 0.2 72.2±4.1 66.6±3.4b
(7.7)
62.0±6.9b
(14.1)
54.0±3.4ab
(25.2)
49.0±3.9 ab
(32.1)
Aqueous
Extract
200 73.0±4.0 69.6±4.0
(4.7)
64.0±4.2b
(12.3)
56.0±4.9ab
(23.3)
50.6±5.8ab
(30.7)
abP< 0.05 compared to control and pre-treatment values respectively (t-test). Values in parenthesis represent reduction
(%) in fasting blood levels glucose levels of normoglycaemic rats calculated relative to pre-treatment values.
Table 1. Effects of Aqueous extract of P. amarus on blood glucose of normoglycaemic rats (n=5; mean ± SD.).
Treatment Dose
mg/kg
Blood Glucose level (mg/dl)
0 min 30min 60min 90min 120min 150min 180min
Control 2ml/kg 61.4±1.9 74.4±4.6
(21.2)
78.0±7.0
(27.0)
73.2±5.8
(19.2)
69.8±5.5
(13.7)
63.2±7.1
(2.9)
59.6±5.1
(2.9)
Glibenclamide 0.2 65.0±2.8 67.8±2.7
(4.3)
70.2±4.0a
(8.00)
66.8±4.1
(2.8)
64.2±7.8(1.
2)
62.4±1.5(4.
00)
61.8±1.8(4.9)
Aqueous
Extract
200 62.6±6.7 73.2±7.5a
(16.9)
80.2±6.7a
(28.1)
72.8±4.5a
(16.3)
64.2±3.5
(2.6)
55.4±5.8
(11.5)
49.4±4.6a
(21.1)
Aqueous Extract 400 62.0±9.0 65.4±6.2
(5.5)
67.0±5.4
(8.1)
63.4±4.7
(2.3)
59.6±3.8
(3.9)
54.0±2.3
(12.9)
50.6±2.2a
(12.4)
aP< 0.05 compared to 0 minute values (t-Test). Superscripted items (a) indicate significant values when compared to 0
min values. Values in parenthesis represent change (%) in blood glucose level calculated relative to 0 min.
Table 2. Effects of aqueous extract of Phyllanthus amarus on oral glucose tolerance in rats (n=5; mean ± SD.)
Treatment Dose
mg/kg
Blood Glucose level (mg/dl)
Pretreatment 0.5hr 1hr 2hr 4hr
Control 2ml/kg 311.0±33.8 298.0±34.3 282.0±31.2 268.0±24.8 256.0±24.2
Glibenclamide 0.2 290.0±26.1 268.0±27.7
(7.6)
252.0±27.1
(13.1)
228.0±17.2ab
(21.4)
208.0±16.3ab
(28.3)
Aqueous
Extract
200 296.0±39.3 276.0±32.2
(6.8)
256.0±35.1
(13.5)
230.0±36.9b
(22.3)
204.0±43.1ab
(31.1)
Aqueous
Extract
400 276.0±24.2 256.0±20.6a
(7.3)
236.0±20.6ab
(14.5)
217.0±24.4ab
(21.4)
200.0±18.7ab
(27.5)
abP< 0.05 compared to control and pre-treatment values respectively (t-Test). Superscripted items (ab) indicate signifi‐
cant values when compared to control and pre-treatment values respectively. Values in parenthesis represent reduc‐
tion (%) in blood glucose level calculated relative to pre treatment values.
Table 3. Hypoglycaemic effects of aqueous extract of P. amarus on diabetic rats (n=5; mean ± SD.)
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Following oral administration of glucose, postprandial blood glucose levels of the control
rats increased to the peak at 60min. Pre-treatment with aqueous extract (200 and 400mg/kg)
suppressed the rise in blood glucose by 28.1 and 8.1% respectively. The aqueous extract
used in this study evoked a progressive dose-dependent decrease in blood glucose level up
to 180mins. Chronic oral administration of aqueous extract caused a significant (P<0.05)
dose-related reduction in blood glucose of diabetic rats. The extract at dose of 400mg/kg re‐
duced the blood glucose of the treated rats better than glibenclamide; while the extract at
200mg/kg exerts almost the same effect as glibenclamide. The highest reduction in the blood
glucose was 60.9% and this was obtained with the 400mg/kg on 28th day (Table 4). In this
study, daily oral administration of the extract for 28 days produced a gradual but sustained
reduction in blood glucose levels in diabetic rats. Alloxan causes hyperglycaemia and glu‐
cose intolerance or syndromes similar to either type 1 or type 2 DM (Lenzen et al., 1996:
Frode and Medeiros, 2008). Effective and sustained reduction in blood glucose levels of
treated diabetic rats by the extract indicates that the plant may be useful in overt cases of
DM. Effective control of blood glucose level is a key step in preventing and reversing diabet‐
ic complications, and improving the quality of life of diabetic patients (Bavarva and Nara‐
simhacharya, 2008).
Treatment Dose
mg/kg
Blood glucose concentration (mg/dl)
Pre-Diabetic
(Basal)
Diabetic
(Pretreatment)
Diabetic Post-Rx
Day 14 Day 28
Control
(NDNT)
2ml/kg 57.4±6.2 58.8±5.8 69.2±4.6a 86.6±4.6a
Control
(NDT)
200 54.8±8.4 56.8±8.7 70.8±7.4a 90.2±5.5a
Glibenclamide 0.2 56.2±5.2 290±26.1 148.0±13.3a
(49.0)
122.0±9.3a
(57.9)
Aqueous Extract 200 55.0±5.0 296.0±32.3 140.0±20.7a
(52.7)
126±19.9a
(57.4)
Aqueous Extract 400 53.4±3.3 276.0±24.2 132.0±17.2a
(52.2)
107.8±5.0a
(60.9)
aP< 0.05 compared to diabetic pre-treatment values (t-Test). Superscripted items (a) indicate significant values when
compared to diabetic pre-treatment values. NDNT= Non-diabetic non-treated was a non-diabetic control and received
the vehicle; NDT= Non-diabetic treated was a non-diabetic control and received AE (200mg/kg). Values in parenthesis
represent reduction (%) in blood glucose level calculated for treatment groups relative to diabetic pre-treatment val‐
ues.
Table 4. Effect of Aqueous extract of P. amarus on blood glucose of diabetic rats (n=5; mean ± SD.)
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Treatment Dose
mg/kg
Parameters Total Cholesterol (mg/dl); Triglycerides (mg/dl); Haemoglobin (g%)
PreDiabetic
(Basal)
Diabetic
(Pre-Rx)
Diabetic Post-Rx
Day 14 Day 28
Control
(NDNT)
2ml/kg Cholesterol
Triglycerides
Hb
122.4±7.3
114.0±5.7
14.6±0.5
124.6±5.20
115.8±7.4
13.8±0.6
124.0±9.7 (0.5)
126.4±14.7
(-9.2)
14.0±1.3
126.2±4.6 (-1.3)
117.6±13 (-1.6)
13.3±1.2
Control
(NDT)
200 Cholesterol
Triglycerides
Hb
117.2±7.8
106.4±9.0
14.4±1.1
111.0±9.9
109.6±6.5
14.0±0.9
109.6±8.5 (1.3)
92.6±11.6b (15.5)
15.5±1.1
105.8±7.9a (4.7)
85.4±9.5ab(22.1)
14.1±2.3
Glibenclamide 0.2 Cholesterol
Triglycerides
Hb
120.8±8.3
104.2±11.2
14.8±1.0
115.0±14.1
119.4±7.5
13.9±0.8
118.8±8.6 (-3.3)
111.2±5.0 (6.0)
15.4±1.0b
110.6±5.2a (3.8)
104.0±4.3b (12.9)
14.3±0.4
Aqueous Extract 200 Cholesterol
Triglycerides
Hb
118.6±4.7
114.2±6.1
15.4±2.0
128.0±2.8
142.0±9.0
14.8±1.8
95.0±7.1ab (25.8)
124.8±5.2ab
(12.1)
15.4±0.7
88.4±7.1ab (30.9)
109.6±7.6b (22.8)
15.2±1.1
Aqueous Extract 400 Cholesterol
Triglycerides
Hb
115.0±7.1
114.0±9.2
15.8±1.5
123.2±9.1
121.0±8.8
14.6±1.8
100.0±7.1ab (18.8)
115.2±7.8 (4.8)
15.2±0.8
87.0±5.1ab (29.4)
105.6±9.4b (12.7)
14.7±0.8
abP<0.05 compared to Basal and Diabetic pre-treatment values respectively (t-Test); Superscripted items (ab) indicate
significant values when compared to control and pre-treatment values respectively. NDNT=Non diabetic non treated
was a non diabetic control and received the vehicle, NDT = Non diabetic treated was a non diabetic control and re‐
ceived aqueous extract (200mg/kg). Values in parenthesis represent reduction (%) of total cholesterol and triglycer‐
ides calculated for treatment groups relative to diabetic pre-treatment values.
Table 5. Effect of Aqueous extract of P. amarus on Cholesterol, triglycerides and haemoglobin levels of diabetic rats
(n=5; mean ± SD.)
Chronic administration of aqueous extract reduced total cholesterol level of diabetic rats.
The aqueous extract caused a significant (P<0.05) reduction in the total cholesterol of treated
diabetic rats. The magnitude of reduction was greater than that evoked by glibenclamide.
Chronic administration of aqueous extract reduced triglyceride concentration of the diabetic
rats. The aqueous extract caused a significant (P<0.05) reduction in the triglyceride level of
treated diabetic rats. The magnitude of reduction was greater than that evoked by glibencla‐
mide. The haemoglobin level of all the animals was increased initially on day 14 with no sig‐
nificant difference except for the glibenclamide-treated animals. Subsequently, there was
reduction in the haemoglobin level on day 28 (Table 5). Diabetic dyslipidaemia is marked by
elevated triglycerides, cholesterol and low density lipoprotein (LDL) particles of altered
composition and decreased high density lipoprotein (HDL), and constitutes an important
cardiovascular risk factor in diabetics (Agrawal et al., 2006). Reduction in total cholesterol
and triglycerides through dietary or drug therapy has been found beneficial in preventing
diabetic complications as well as improving lipid metabolism in diabetic patients (Brown et
al., 1993; Ahmed et al., 2001). Experimentally, alloxan-induced diabetic hyperglycaemia is
accompanied by increase in serum cholesterol and triglyceride levels (Choi et al., 1991;
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Ahmed et al., 2001; Okoli et al., 2010) and mimics overt diabetes disease. Thus, in addition to
glycaemic control, extract of this plant may further reduce mortality from complications of
the disease by ameliorating diabetes-induced dislipidaemia. The RBC count of all the ani‐
mals was reduced on day 14 with all the groups showing significant difference except the
400mg/kg dose of the aqueous extract. Subsequently, there was increase in the RBC count on
day 28 with all the groups showing significant difference with the exception of the
400mg/kg dose of the aqueous extract. The white blood cell (WBC) count of all the control
and glibenclamide- treated animals was reduced initially on day 14 with no significant dif‐
ference; while there was increase in the WBC count of the extract-treated group on day 14
and the increase continued on day 28 with the 400mg/kg dose of the extract showing signifi‐
cant difference. Likewise, there was subsequent increase in the control (both NDT and
NDNT) groups and glibenclamide-treated group on day 28 with no significant difference
(Table 6). Again, assessment of the effect of chronic administration of the extracts on haemo‐
globin level as well as white blood cell and red blood cell counts revealed an increase fol‐
lowing an initial reduction in most cases of the experiment. It is not clear if it would
progress to a return to basal levels and how long it may take.
Treatment Dose
mg/kg
Parameters RBC (X106/µL); WBC (X103/µL)
PreDiabetic
(Basal)
Diabetic
(Pre-Rx)
Diabetic Post-Rx
Day 14 Day 28
Control
(NDNT)
2ml/kg RBC
WBC
5.2±0.1
4.8±0.3
4.9±0.1
4.8±0.3
4.6±0.1ab
4.8±0.3
6.8±0.7ab
4.9±0.3
Control
(NDT)
200 RBC
WBC
5.2±0.1
5.0±0.3
5.1±0.03
4.9±0.3
4.9±0.1ab
4.8±0.3
5.0±0.2a
5.1±0.03
Glibenclamide 0.2 RBC
WBC
5.6±0.2
4.7±0.6
5.3±0.3
5.0±0.5
4.8±0.3ab
4.7±0.2
5.4±0.2
4.8±0.1
Aqueous Extract 200 RBC
WBC
5.2±0.1
4.8±0.3
5.1±0.1
4.8±0.3
4.8±0.2ab
5.0±0.3
5.4±0.1ab
5.1±0.3
Aqueous Extract 400 RBC
WBC
4.8±0.4
4.9±0.2
4.6±0.3
4.8±0.2
4.6±0.1
5.0±0.1
4.8±0.1
5.2±0.1ab
abP<0.05 compared to Basal and Diabetic pre-treatment values respectively (t-Test); Superscripted items (ab) indicate
significant values when compared to control and pre-treatment values respectively. NDT = Non diabetic treated was a
non diabetic control and received aqueous extract (200mg/kg); NDNT = Non diabetic non treated was a non diabetic
control and received the vehicle.
Table 6. Effect of Aqueous extract of P. amarus on the Red Blood Cell (RBC) and White Blood Cell (WBC) counts of
diabetic rats (n=5; mean ± SD.)
There was increase in the body weight of all the groups on day 14 and the increase contin‐
ued on day 28 with the 400mg/kg dose of aqueous extract showing significant difference
(P<0.05). The weight increase occurred most in the NDT control group followed by the
NDNT control group and then the 400mg/kg dose of aqueous extract (Table 7). Due to the
association of obesity with DM, weight control is an important aspect of diabetes manage‐
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ment. Poor glycaemic control usually results in weight loss. The results showed that all the
animals used gained weight during the study. The weight gain was highest in the nondia‐
betic treated control while glibenclamide-treated control has modest weight gain. In some
cases however, adequate glycaemic control by some agents may lead to increase in body
weight such as that observed with the thiazolidinediones (Monnier et al., 2003; Bhat et al.,
2007). The result showed that at 400mg/kg dose, aqueous extract showed a significant in‐
crease in body weight. It is also important to note that chronic administration of the extracts
did not inhibit the natural growth process of these animals with or without diabetes.
Treatment Dose mg/kg Body weight (g)
Pre-Diabetic
(Basal)
Diabetic
(Pre-Rx)
Diabetic Post-Rx
Day 14 Day 28
Control
(NDNT)
2ml/kg 214.0±11.2 209.0±14.1 226.6±10.4
(8.4)
231.8±7.68 (10.91)
Control
(NDT)
200 135.0±36.9 137.0±35.9 150.0±37.5
(8.7)
157.0±38.43
(14.60)
Glibenclamide 0.2 191.0±34.6 188.0±37.9 196.0±33.9
(4.3)
200.0±32.6
(6.4)
Aqueous Extract 200 196.0±18.1 192.0±18.2 206.6±20.9
(7.6)
211.0±22.2 (9.9)
Aqueous Extract 400 214.0±15.0 212.0±13.0 228.0±7.8b
(7.6)
234.0±5.8ab
(10.4)
abP<0.05 compared to Basal and Diabetic pre-treatment values respectively (t-Test); Superscripted items (ab) indicate
significant values when compared to control and pre-treatment values respectively. NDT = Non diabetic treated was a
non diabetic control and received AE (200mg/kg); NDNT = Non diabetic non-treated was a non diabetic control and
received the vehicle. Value in parenthesis represents percentage increase (%) of body weight calculated for treatment
groups relative to diabetic pre-treatment values.
Table 7. Effect of chronic administration of aqueous extract of Phyllanthus amarus on body weight of diabetic rats
(n=5; mean ± SD.).
Histological examination of the pancreas shows the necrosis of the islet tissues with the al‐
veolar cells moderately destroyed; there was also moderate congestion of the blood vessels
(Figure 1) in the diabetic non-treated group. In the extract-treated group, the architecture of
the pancreas appeared intact. The interlobular, intralobular and the alveolar granules were
seen (Figure 2). There was slight necrosis of the pancreas around the islet tissues in the gli‐
benclamide-treated group (Figure 3). Microscopical examination of liver section of diabetic
non-treated group (Figure 4) showed various degrees of pathological changes such as centri‐
lobular fatty degeneration, cloudy swelling, and vacuolar change of the hepatocytes as well
as necrosis of hepatic cells. Microscopical examination of liver section of diabetic extract-
treated control group (Figure 5) showed normal arrangement of hepatocytes with clear
broad of central vein at portal layer. The histopathological study showed recovery of the
damaged liver cells in the extract- treated group. The liver of the glibenclamide-treated
group showed widespread vacuolar change of the hepatocytes (figure 6). Microscopical ex‐
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amination of the kidney section of diabetic non-treated control showed moderate loss of re‐
nal tubules and congestion of renal blood vessels in the medulla (figure 7). There was no
visible lesion seen in the extract-treated (figure 8). There was no visible lesion seen in the
glibenclamide-treated group (Figure 9). Several factors such as oxidative stress (Hayden et
al., 2005), chronic hyperglycaemia (Leung and Leung, 2008) and autoimmune (Yoshida et
al., 1995) or fibrocalculous (Mohan et al., 2008) types of chronic pancreatitis damage the pan‐
creas and impair insulin secretion and hence glycaemic control. Results of histological stud‐
ies on pancreas isolated from treated diabetic rat showed that the extract may have repaired
the pancreas damaged by alloxan. Alloxan causes diabetes by destruction of ß-cells of the
islet (Szudelski, 2001; Frode and Medeiros, 2008) which consequently impairs insulin secre‐
tion and gives rise to hyperglycemia. Treatment with the extract may have restored the in‐
tegrity and perhaps, functions of the damaged pancreatic tissues. Also, the extract was able
to restore the damaged kidney and liver to their normal architecture. Glibenclamide used as
a reference hypoglycemic agent did not cause such effect to the same extent as the extract
(Figures 1-9). The precise mechanism of this tissue repair is not known. However, due to the
large implication of oxidative stress (Hayden et al., 2005; Leung and Leung, 2008) in damage
to the pancreas, it seems reasonable to suggest that the antioxidant (Tasaduq et al., 2003) and
radical scavenging (Jagetia and Baliga, 2004) effects of this plant may play a key role in pro‐
tecting pancreatic tissues from oxidants including that generated by alloxan. Alloxan de‐
stroys insulin-producing pancreatic ß-cells through the formation of reactive oxygen species
that cause tissue damage (Lee et al., 2008).
Figure 1. Pancreas of diabetic non-treated rat (X400)
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Figure 2. Effect of P. amarus extract on the pancreas of alloxan-induced diabetic rats (X400)
Figure 3. Effect of glibenclamide on the pancreas of alloxan-induced diabetic rat (X400)
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Figure 4. Liver section of diabetic non-treated group (X400)
Figure 5. Effect of P. amarus extract on the liver of alloxan-induced diabetic rats (X400)
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Figure 6. Effect of glibenclamide on the Liver of alloxan-induced diabetic rat (X400)
Figure 7. Kidney section of diabetic non-treated group (X400)
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Figure 8. Effect of P. amarus extract on the kidney of alloxan-induced diabetic rats (X400)
Figure 9. Effect of glibenclamide on the kidney of alloxan-induced diabetic rat (X400)
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6. Conclusion
While the antidiabetic effect of the extract may derive from its hypoglycaemic effect, the
mechanisms of the hypoglycaemic effect are yet to be elucidated. The hypoglycaemic effect
in normal and diabetic rats suggests an insulin-like effect probably mediated via peripheral
glucose consumption (De Sousa et al., 2004; Zanatta et al., 2007). Also, postprandial hyper‐
glycemia is related to postprandial hyperinsulinemia (Wang et al., 2004) and its suppression
by the extract suggests an insulin-like effect. Phytochemical analysis of the extract revealed
the presence of flavonoids, alkaloids, glycosides and tannins which are typical plant constit‐
uents. Thus there are chances that any of these constituents may possess anti-diabetic prop‐
erties. The histological studies also indicated that 0.2mg/kg of glibenclamide produced some
histological changes whereas the 200 and 400 mg/kg doses of the plant extracts did not pro‐
duce any histological change. This showed that this plant is not only effective as medicinal
agent but also has high safety margin.
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